Nada Stefanovic
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
- Biochemistry top 5%
Papers in
-
- Peroxisome Proliferator-Activated Receptors 2
- Genomics, phytochemicals, and oxidative stress 2
- Redox biology and oxidative stress 2
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Atherosclerosis and Cardiovascular Diseases 2
- Co-authors
- Judy B. de Haan (16 shared papers)Arpeeta Sharma (8 shared papers)Mark E. Cooper (4 shared papers)Ismail Kola (5 shared papers)Derek Y.C. Yuen (5 shared papers)Karin Jandeleit‐Dahm (3 shared papers)Josefa Pete (4 shared papers)Sih Min Tan (5 shared papers)
- Journals
- Diabetes (4 papers)Investigative Ophthalmology & Visual Science (2 papers)Atherosclerosis (2 papers)Circulation (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Nada Stefanovic
17 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Clinical Biochemistry 135
- Biochemistry 81
- Biochemistry 64
- Immunology 211
- Toxicology 34
Countries citing papers authored by Nada Stefanovic
This map shows the geographic impact of Nada Stefanovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada Stefanovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada Stefanovic more than expected).
Fields of papers citing papers by Nada Stefanovic
This network shows the impact of papers produced by Nada Stefanovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada Stefanovic. The network helps show where Nada Stefanovic may publish in the future.
Co-authors
The 25 scholars most cited alongside Nada Stefanovic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 211 | |
| 2 | 2020 | 121 | |
| 3 | 2010 | 105 | |
| 4 | 2014 | 98 | |
| 5 | 2017 | 79 | |
| 6 | 2009 | 74 | |
| 7 | 2013 | 60 | |
| 8 | 2015 | 56 | |
| 9 | 2005 | 55 | |
| 10 | 2015 | 50 | |
| 11 | 2006 | 44 | |
| 12 | 2013 | 41 | |
| 13 | 2015 | 38 | |
| 14 | 2013 | 29 | |
| 15 | 2006 | 28 | |
| 16 | 2014 | 8 | |
| 17 | 2015 | 2 |
About Nada Stefanovic
Nada Stefanovic is a scholar working on Molecular Biology, Immunology, Nephrology, Physiology and Toxicology, having authored 17 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers) and Redox biology and oxidative stress (2 papers). The work is most often cited by research in Clinical Biochemistry (135 citations), Biochemistry (81 citations), Biochemistry (64 citations), Immunology (211 citations) and Toxicology (34 citations). Nada Stefanovic has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Judy B. de Haan, Arpeeta Sharma, Mark E. Cooper, Ismail Kola, Derek Y.C. Yuen, Karin Jandeleit‐Dahm, Josefa Pete, Sih Min Tan, Keith W. Ward and Rebecca H. Ritchie. Their work appears in journals such as Diabetes, Investigative Ophthalmology & Visual Science, Atherosclerosis, Circulation and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.